CN103566235A - Medicine for treating hepatitis B - Google Patents
Medicine for treating hepatitis B Download PDFInfo
- Publication number
- CN103566235A CN103566235A CN201310533013.0A CN201310533013A CN103566235A CN 103566235 A CN103566235 A CN 103566235A CN 201310533013 A CN201310533013 A CN 201310533013A CN 103566235 A CN103566235 A CN 103566235A
- Authority
- CN
- China
- Prior art keywords
- grams
- medicine
- hepatitis
- liver
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 36
- 208000002672 hepatitis B Diseases 0.000 title claims abstract description 29
- 229940079593 drug Drugs 0.000 title claims description 6
- 210000000582 semen Anatomy 0.000 claims abstract description 5
- 239000002994 raw material Substances 0.000 claims abstract 2
- 235000003826 Artemisia Nutrition 0.000 claims description 4
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims description 4
- 241000756943 Codonopsis Species 0.000 claims description 4
- 235000009052 artemisia Nutrition 0.000 claims description 4
- 241000545442 Radix Species 0.000 claims description 3
- 240000006891 Artemisia vulgaris Species 0.000 claims 1
- 210000004185 liver Anatomy 0.000 abstract description 16
- 230000000694 effects Effects 0.000 abstract description 15
- 210000000952 spleen Anatomy 0.000 abstract description 15
- 210000002784 stomach Anatomy 0.000 abstract description 11
- 208000002193 Pain Diseases 0.000 abstract description 9
- 208000024891 symptom Diseases 0.000 abstract description 7
- 230000001737 promoting effect Effects 0.000 abstract description 4
- 230000001105 regulatory effect Effects 0.000 abstract description 3
- 239000009636 Huang Qi Substances 0.000 abstract description 2
- 238000005728 strengthening Methods 0.000 abstract description 2
- 241000132012 Atractylodes Species 0.000 abstract 1
- 244000183685 Citrus aurantium Species 0.000 abstract 1
- 235000007716 Citrus aurantium Nutrition 0.000 abstract 1
- 241001660870 Cyrtomium Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 241000830535 Ligustrum lucidum Species 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 239000003053 toxin Substances 0.000 abstract 1
- 231100000765 toxin Toxicity 0.000 abstract 1
- 108700012359 toxins Proteins 0.000 abstract 1
- 241000700721 Hepatitis B virus Species 0.000 description 13
- 208000006454 hepatitis Diseases 0.000 description 9
- 231100000283 hepatitis Toxicity 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 4
- 206010023126 Jaundice Diseases 0.000 description 4
- 230000001684 chronic effect Effects 0.000 description 4
- 208000019425 cirrhosis of liver Diseases 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 208000000059 Dyspnea Diseases 0.000 description 3
- 206010013975 Dyspnoeas Diseases 0.000 description 3
- 208000019255 Menstrual disease Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 208000031971 Yin Deficiency Diseases 0.000 description 3
- 244000030166 artemisia Species 0.000 description 3
- 230000005540 biological transmission Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000002950 deficient Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 210000003494 hepatocyte Anatomy 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010008909 Chronic Hepatitis Diseases 0.000 description 2
- 229940124872 Hepatitis B virus vaccine Drugs 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 206010033425 Pain in extremity Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 239000010836 blood and blood product Substances 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 206010013990 dysuria Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 208000013220 shortness of breath Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 208000006678 Abdominal Neoplasms Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 208000032484 Accidental exposure to product Diseases 0.000 description 1
- 206010059193 Acute hepatitis B Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003399 Arthropod bite Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 208000000419 Chronic Hepatitis B Diseases 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 201000006306 Cor pulmonale Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 241000498255 Enterobius vermicularis Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 206010018045 Gastroptosis Diseases 0.000 description 1
- 206010019663 Hepatic failure Diseases 0.000 description 1
- 206010019755 Hepatitis chronic active Diseases 0.000 description 1
- 208000004356 Hysteria Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 206010050819 Musculoskeletal chest pain Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 208000037581 Persistent Infection Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 206010047531 Visual acuity reduced Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 231100000818 accidental exposure Toxicity 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000037628 acute hepatitis B virus infection Diseases 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- XEGGRYVFLWGFHI-UHFFFAOYSA-N bendiocarb Chemical compound CNC(=O)OC1=CC=CC2=C1OC(C)(C)O2 XEGGRYVFLWGFHI-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 229940125691 blood product Drugs 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 206010014881 enterobiasis Diseases 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000010135 fructus aurantii immaturus Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 231100000835 liver failure Toxicity 0.000 description 1
- 208000007903 liver failure Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000008359 toxicosis Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 230000005570 vertical transmission Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000009978 visual deterioration Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000002918 waste heat Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to a medicine for treating hepatitis B. The medicine comprises the following traditional Chinese medicine raw materials by weight: 10g of radix astragali, 10g of dangshen, 10g of semen coicis, 10g of white paeony root, 15g of salvia miltiorrhiza, 10g of cyrtomium rhizome, 30g of herba artemisiae scopariae, 15g of glossy privet fruit, 10g of largehead atractylodes rhizome, 10g of fructus toosendan, 9g of radix bupleuri, 9g of liquorice and 9g of immature bitter orange. The precision of the medicine ratio is +/-5%. Clinical use proves that the medicine for treating hepatitis B has the functions of nourishing yin and soothing the liver, strengthening the spleen and stomach, regulating qi to alleviate pain, tonifying qi and removing toxins, promoting antibody formation and protecting the liver; after being taken by patients for 1-2 courses of treatment, the medicine can not only relieve the symptoms when being taken but also thoroughly cure hepatitis B after being taken, has a quite obvious curative effect, does not have toxic or side effect and is low in price.
Description
Technical field
The present invention relates to a kind of technical field of Chinese medicines, specifically a kind of medicine for the treatment of hepatitis B.
Background technology
Hepatitis B, is called for short hepatitis B, is a kind of by caused disease after hepatitis B virus (HBV) infection body.Hepatitis B virus is a kind of Hepadna Virus, is mainly present in hepatocyte and damages hepatocyte, causes hepatocyte inflammation, necrosis, fibrosis.Hepatitis B is divided acute and chronic two kinds.Acute hepatitis B 90% can spontaneous recovery in adult, and chronic hepatitis B performance differs, and is divided into HBV chronic carrier, chronic active hepatitis B, hbv-liver cirrhosis etc.The current hepatitis B virus carrying rate of China is 7.18%, and wherein approximately 1/3rd have hepatic injury repeatedly, shows as hepatitis B or the liver cirrhosis of activeness.Along with applying of Hepatitis B virus vaccine, China's hepatitis B virus infection rate declines year by year, and 5 years old following child's HBsAg carrying rate is only 0.96%.
It is worldwide popular that hepatitis B infection is, the epidemic strength that different regions HBV infects is widely different, according to worldwide health organization, the whole world approximately 2,000,000,000 people once infected HBV, wherein 3.5 hundred million people are chronic infection person, approximately have every year 1000000 people die from HBV infect due to liver liver failure, liver cirrhosis and primary hepatocarcinoma (HCC).
The survey showed that for the prevalence of hepatitis B virus that China carried out in 2006, China 1-59 crowd hepatitis B surface antigen carrying rate is 7.18%, 5 years old following children's HBsAg carrying rate is only 0.96%, calculate accordingly, the existing Patients with Chronic HBV Infection of China approximately 9,300 ten thousand people, wherein have the activeness hepatitis B patient that symptom need to be treated to be about more than 2,000 ten thousand.
Hepatitis B is blood transmissible disease, main menses (as unsafe injection history etc.), mother-to-baby transmission and spread through sex intercourse, mucocutaneous damaged propagation also has certain proportion, as tatoo, Zha Erdong, splanchnoscopy etc., blood products is now strictly controlled, diffusibility greatly reduces, and just has generation during Blood and blood products transfusion lack of standardization.Accidental exposure in medical worker's work also can not be ignored.Along with Hepatitis B virus vaccine wideling popularize in neonate, and other mother and baby blocks the enforcement of measure, and mother-to-baby transmission is greatly controlled.HBV-DNA Positive Mothers childbirth at present approximately has 90 percent by intervening, successfully to block vertical transmission.HBV infects without respiratory tract, transmission, therefore daily study, work or life contact, as same office office appliances such as () shared computers, live a dormitory together, have a dinner in same dining room and embrace, shake hands, share lavatory etc. and can not infect HBV.Epidemiology and experimentation do not find that hepatitis B can be through hematophagus, as mosquito, bedbug bite are propagated.
At present, B-type hepatitis is that not only deficiency and excess was held concurrently but also cold and heat are held concurrently mutually mutually from tcm diagnosis and treatment, in addition hepatitis B virus is to hepatocellular destruction, consume a large amount of albumen of human body, make B-type hepatitis be difficult to radical cure, the Chinese medicine formula of the treatment B-type hepatitis of prior art can be said much, still can stably improve the medicine of body immunity and inhibition, elimination hepatitis B virus, promotion liver cell regeneration, particularly to serious symptom B-type hepatitis people, can have the few of good therapeutic effect.
Summary of the invention
The object of the invention is to overcome the deficiencies in the prior art, provide a kind of and there is the merit of strengthening vital QI to eliminate pathogenic factors, the medicine of the treatment hepatitis B of the use of tonification internal organs, cold not hot not dry, the energy with cleaning hepatic diseases poison, can reach the effect for the treatment of preferably B-type hepatitis, particularly the B-type hepatitis patient of serious symptom can be pulled through and cure.Through clinical use demonstration, this medicine is relief of symptoms in use not only, and, can thorough treating hepatitis B after use, particular significant effect, has no side effect.
The technical solution adopted for the present invention to solve the technical problems is: a kind of medicine for the treatment of hepatitis B, and it is mainly comprised of following traditional Chinese medicine raw:
Composition of the present invention and proportioning:
10 grams of the Radixs Astragali, 10 grams of Radix Codonopsis, 10 grams of meaning Semen Coicis, 10 grams of the Radix Paeoniae Albas, 15 grams of Radix Salviae Miltiorrhizaes, 10 grams of Rhizoma Osmundae, 30 grams of Artemisia anethoicles Mattf, 15 grams of Fructus Ligustri Lucidi, 10 grams of the Rhizoma Atractylodis Macrocephalaes, 10 grams of Fructus Toosendan, 9 grams of Radix Bupleuri, 9 grams, Radix Glycyrrhizae, 9 grams of Fructus Aurantii Immaturuss.The degree of accuracy of above drug ratio is positive and negative 5%.
The pharmacology of this medicine is:
The Radix Astragali: nature and flavor: sweet, tepor.Gui Jing: return lung, spleen, liver, kidney channel.There is enhancing human body immunity function, protect the liver, diuresis, defying age, anti-stress, blood pressure lowering and antibacterial action more widely.
Radix Codonopsis: property is flat, sweet in the mouth, micro-acid.Return spleen, lung meridian.Invigorating the spleen and replenishing QI, spleen invigorating lung benefiting.For deficiency of the spleen and lung, the cardiopalmus of breathing hard, anorexia and loose stool, dyspnea due to deficiency cough, interior-heat is quenched one's thirst.
Meaning Semen Coicis: sweet, be slightly cold, nontoxic.Cure mainly arthralgia chiefly caused by damp pathogen, sharp the intestines and stomach, consumer edema.Kernel is not only good nutriment, and has diuresis and antitumaous effect.Be applicable to beriberi edema, the carcinoma initial stage.Its root is for driving ascarid medicine.
The Radix Paeoniae Alba: picric acid, is slightly cold.Enter liver, spleen channel.Nourishing blood to suppress the hyperactive liver, slow middle pain relieving, yin fluid astringing is received antiperspirant.Control the breast abdomen pain over the hypochondriac region, dysentery stomachache, spontaneous sweating, fever due to yin deficiency, menoxenia, metrorrhagia, leukorrhagia.
Radix Salviae Miltiorrhizae: bitter in the mouth, cold nature; GUIXIN, Liver Channel.For menoxenia due to blood stasis, dysmenorrhea, amenorrhea, the stagnant stomachache of the stasis of blood in puerperal; Angina pectoris, atherosclerosis; Chronic hepatitis, liver cirrhosis, abdominal masses or tumor; Chronic cardiopulmonary disease, bronchial asthma; Blood failing to tonify the heart or heart-fire are partially high, palpitation and restlessness, vexed insomnia.
Rhizoma Osmundae: bitter, puckery, be slightly cold.Return liver, stomach warp.Heat-clearing and toxic substances removing, hemostasis, parasite killing.For anemopyretic cold, encephalitis B, mumps, dysentery, discharging fresh blood stool, metrorrhagia, leukorrhagia, puerperal vim and vigour distending pain, ascarifuge and pinworm, pathopyretic ulcer.
Artemisia anethoicles Mattf: mildly bitter flavor; Micro-pungent; Cold nature.Return spleen; Stomach; Urinary bladder channel.Clearing away heat-damp and promoting diuresis; Jaundice eliminating.Cure mainly jaundice oliguria, dysuria, eczema pruritus, infectious jaundice type hepatitis.
Fructus Ligustri Lucidi: nature and flavor: sweet, hardship, flat.Gui Jing: liver; Kidney channel liver and kidney tonifying, clearind deficient heat, strong waist knee joint, improve visual and auditory acuity, black beard and hair.For the poor vision of the hepatic and renal YIN deficiency, visual deterioration, early whitening of beard and hair, soreness of waist tinnitus and fever due to yin deficiency etc.This product energy tonifying liver kidney yin, but the efficacy of a drug is gentle, must slowly get effect.
The Rhizoma Atractylodis Macrocephalae: bitter, sweet, temperature.Return spleen, stomach warp.Spleen reinforcing, stomach reinforcing, dampness, and in, antiabortive.Control deficient QI of the spleen and stomach, anorexia, asthenia weak breath, deficiency-distension, has loose bowels, phlegm retention, edema, jaundice, arthralgia chiefly caused by damp pathogen, dysuria, dizziness, spontaneous perspiration, nausea is uneasy.
Fructus Toosendan: hardship, cold; Slightly poisonous.Return liver, small intestinal, urinary bladder channel.Soothing liver-QI promoting the circulation of QI to relieve pain, except damp and hot, anthelmintic.For the breast side of body, abdominal distention, colic, abdominal pain due to worm stagnation.
Radix Bupleuri: cold nature, bitter in the mouth, pungent, return Liver Channel, gallbladder meridian, tool depressed liver-energy dispersing and function of gallbladder promoting, dredge gas resolving depression, loose effect of fire.Heating, cold and heat deficient fever cure cold.Children's's varioliform exanthema waste heat, emaciation and sallow complexion abdominal part expands, malaria, stagnation of QI due to depression of the liver, sternal rib pain, proctoptosis, uterus comes off, menoxenia.
Radix Glycyrrhizae: sweet, flat.Enter spleen, stomach, lung meridian.QI invigorating invigorating middle warmer; Relieving spasm to stop pain; Nourishing the lung to arrest cough; Eliminating fire and detoxication; Coordinating the actions of various ingredients in a prescription.Main asthenia lack of appetite; Leanness yellowish complexion; Shortness of breath and palpitation; Stomachache loose stool; The anxious pain of extremity contraction; Hysteria; Cough and asthma; Laryngopharynx swelling and pain; Carbuncle skin ulcer swells and ache; Infantile carbuncle; And medicine, alimentary toxicosis.For weakness of the spleen and stomach, fatigue and weakness, shortness of breath and palpitation, cough with copious phlegm, gastral cavity abdomen, the anxious pain of extremity contraction, carbuncle sore tumefacting virus, cushion toxicity, strong.
Fructus Aurantii Immaturus: hardship; Pungent; Cold.Return spleen; Stomach; Liver; Heart channel.In stagnant, stop; Feeling of fullness distending pain; Constipation; Heavy after dysentery; Blocked-up chest; Gastroptosis; Uterine prolapse; Proctoptosis.
Its processing technology and Therapeutic Method are: take 10 grams of the Radixs Astragali, 10 grams of Radix Codonopsis, 10 grams of meaning Semen Coicis, 10 grams of the Radix Paeoniae Albas, 15 grams of Radix Salviae Miltiorrhizaes, 10 grams of Rhizoma Osmundae, 30 grams of Artemisia anethoicles Mattf, 15 grams of Fructus Ligustri Lucidi, 10 grams of the Rhizoma Atractylodis Macrocephalaes, 10 grams of Fructus Toosendan, 9 grams of Radix Bupleuri, 9 grams, Radix Glycyrrhizae, 9 grams of Fructus Aurantii Immaturuss.The degree of accuracy of above drug ratio is positive and negative 5%.
The instructions of taking of this Chinese medicine:, be placed in medicine pot by above medicament mixed together, put into 1000 grams of clear water and soak after 1 hour, big fire is boiled, endures slowly with slow fire, to surplus 400 grams of water, takes potion on the one after room temperature.Every day, supper was taken after 1 hour, and serveing on 30 days is a course for the treatment of, and patient takes 1～2 course for the treatment of, can cure.
The invention has the beneficial effects as follows: the medicine of this treatment hepatitis B, through clinical use demonstration, has nourishing YIN and dispersing the stagnated liver-QI, invigorating the spleen and regulating the stomach, regulating QI to relieve pain, QI invigorating removing toxic substances, facilitates antibody to generate, liver-protective effect.Patient takes 1～2 course for the treatment of, not only can be when taking relief of symptoms, and, after taking, can thorough treating hepatitis B disease, curative effect is remarkable especially, has no side effect, cheap.
Specific embodiment
Through the clinical practice to 100 routine hepatitis Bs over 1 year, obtained good curative effect, total effective rate reaches 98%, and details are as follows for relevant clinical treatment situation:
1. patient profile: select the projects such as medical history, the state of an illness, age and original therapy method.
2. patient originates: with general hospital patient and special chinic patient in hospital.
3. case enters group standard, according to clinical manifestation and the pathological characters of hepatitis B patient, divides, and 15 years old～70 years old age, more than course of disease January～1 year; Medicine and the therapeutic modality of various other treatment hepatitis B of stopping using before treatment.
4. administrated method: patient takes the medicine boiling every day, and once-a-day, every day, supper was taken after 1 hour, and taking continuously 30 days is a course for the treatment of, and patient takes 1～2 course for the treatment of, can cure.
5. efficacy analysis:
(1) course of disease: 1 month～2 months 48 examples, 2 months～3 months 30 examples, 3 months are 22 examples above;
(2) age group: 15 years old～30 years old 25 examples, 31 years old～40 years old 20 examples, 41 years old～50 years old 20 examples, 50 years old above 35 example;
(3) disease type and curative effect: see the following form, administration time is 1～3 course for the treatment of.
By Drug therapy hepatitis B of the present invention, received satisfied curative effect.The symptom of hepatitis B is a lot, before this group case treatment, during most of patients was carried out, the treatment of doctor trained in Western medicine mode, but all do not obtain good curative effect, especially Western medicine is for oral administration, and side effect is larger, human body is caused to very major injury, and most of sufferers all be can't stand drug withdrawal voluntarily because bearing.
In taking the process of medicine of the present invention, must not take Western medicine and use injection, or the medicine of other treatment hepatitis B.
Drug administration of the present invention is without any side effects, evident in efficacy, and its cure rate reaches 95%.
Claims (1)
1. a medicine for the treatment of hepatitis B, is characterized in that: the medicine of this treatment hepatitis B is comprised of the raw material of Chinese medicine of following weight: 10 grams of the Radixs Astragali, 10 grams of Radix Codonopsis, 10 grams of meaning Semen Coicis, 10 grams of the Radix Paeoniae Albas, 15 grams of Radix Salviae Miltiorrhizaes, 10 grams of Rhizoma Osmundae, 30 grams of Artemisia anethoicles Mattf, 15 grams of Fructus Ligustri Lucidi, 10 grams of the Rhizoma Atractylodis Macrocephalaes, 10 grams of Fructus Toosendan, 9 grams of Radix Bupleuri, 9 grams, Radix Glycyrrhizae, 9 grams of Fructus Aurantii Immaturuss; The degree of accuracy of above drug ratio is positive and negative 5%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310533013.0A CN103566235A (en) | 2013-11-04 | 2013-11-04 | Medicine for treating hepatitis B |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310533013.0A CN103566235A (en) | 2013-11-04 | 2013-11-04 | Medicine for treating hepatitis B |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103566235A true CN103566235A (en) | 2014-02-12 |
Family
ID=50039516
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310533013.0A Pending CN103566235A (en) | 2013-11-04 | 2013-11-04 | Medicine for treating hepatitis B |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103566235A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107596317A (en) * | 2017-10-09 | 2018-01-19 | 刘斌 | A kind of composition of medicine for suppressing hepatitis B virus duplication |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1113779A (en) * | 1994-06-17 | 1995-12-27 | 殷广全 | Anti- hepatitis B preparation |
-
2013
- 2013-11-04 CN CN201310533013.0A patent/CN103566235A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1113779A (en) * | 1994-06-17 | 1995-12-27 | 殷广全 | Anti- hepatitis B preparation |
Non-Patent Citations (1)
| Title |
|---|
| 良石等著: "《乙肝怎么看怎么办》", 31 March 2013 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107596317A (en) * | 2017-10-09 | 2018-01-19 | 刘斌 | A kind of composition of medicine for suppressing hepatitis B virus duplication |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103007191B (en) | Chinese medicinal composition for treating jaundice | |
| CN102908603B (en) | Chinese medicament for treating hyperplasia of mammary glands | |
| CN103784887A (en) | Traditional Chinese medicinal composition for treating kidney deficiency lumbago | |
| CN103977366A (en) | Medicine for treating chronic cholecystitis | |
| CN104043022A (en) | Traditional Chinese medicine composition for treating gynecologic inflammation | |
| CN104043050A (en) | Traditional Chinese medicine composition for treating cholecystitis | |
| CN104173856A (en) | Traditional Chinese medicine composition for treating morbid leukorrhea | |
| CN103816497A (en) | Traditional Chinese medicinal composition for treating syndrome of liver qi stagnation | |
| CN102949659B (en) | Traditional Chinese medicine composition for treating hepatitis B | |
| CN103394030B (en) | Traditional Chinese medicine composition for treating depressed liver and deficient spleen | |
| CN103041301B (en) | Traditional Chinese medicine composition for treating icterohepatitis | |
| CN103705870A (en) | Traditional Chinese medicine composition for treating mastitis | |
| CN103816337A (en) | Traditional Chinese medicinal composition for treating delayed menstrual cycle | |
| CN103566235A (en) | Medicine for treating hepatitis B | |
| CN103463397B (en) | Traditional Chinese medicine composition for treating deficiency of kidney-yin | |
| CN106075265A (en) | The Chinese medicine composition for the treatment of viral influenza | |
| CN103990080A (en) | Medicament for treating verruca plana and preparation method thereof | |
| CN103800838A (en) | Traditional Chinese medicine composition for treating deficiency of the kidney-yin | |
| CN104547384A (en) | Oral liquid for treating paraquat poisoning and preparation method of oral liquid | |
| CN103990019A (en) | Traditional Chinese medicine preparation for treating light-headedness | |
| CN103830682A (en) | Traditional Chinese medicine composition for treating liver depression and blood stasis syndromes | |
| CN104189661A (en) | Traditional Chinese medicine for treating fibromyalgia syndrome | |
| CN103007193B (en) | Chinese medicinal composition for treating gallbladder distention | |
| CN101015671B (en) | Chinese patent drug for treating cirrhosis | |
| CN106266985A (en) | A kind of can the pill medicine effectively treating hepatitis B and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140212 |
|
| WD01 | Invention patent application deemed withdrawn after publication |